Business Description
Unichem Laboratories Ltd
ISIN : INE351A01035
Total Employee Number:
3,327Compare
Compare
Traded in other countries / regions
506690.India IPO Date
2001-02-07Description
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.6 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.18 | |||||
Debt-to-EBITDA | 1.11 | |||||
Interest Coverage | 1.77 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.09 | |||||
Beneish M-Score | -1.83 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.1 | |||||
3-Year FCF Growth Rate | 2.7 | |||||
3-Year Book Growth Rate | 3.7 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 72.69 | |||||
9-Day RSI | 68.39 | |||||
14-Day RSI | 66.65 | |||||
3-1 Month Momentum % | 22.99 | |||||
6-1 Month Momentum % | -20.66 | |||||
12-1 Month Momentum % | -40.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.48 | |||||
Quick Ratio | 1.38 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 350.69 | |||||
Days Sales Outstanding | 131.8 | |||||
Days Payable | 128.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -3.98 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 53.65 | |||||
Operating Margin % | 2.54 | |||||
Net Margin % | 11.48 | |||||
EBITDA Margin % | 20.4 | |||||
FCF Margin % | -5.42 | |||||
OCF Margin % | 0.17 | |||||
ROE % | 9.98 | |||||
ROA % | 6.98 | |||||
ROIC % | 1.59 | |||||
3-Year ROIIC % | 47.51 | |||||
ROC (Joel Greenblatt) % | 12.24 | |||||
ROCE % | 12.2 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 12.59 | |||||
PE Ratio without NRI | 60.14 | |||||
Shiller PE Ratio | 22.15 | |||||
Price-to-Owner-Earnings | 29.46 | |||||
PS Ratio | 1.44 | |||||
PB Ratio | 1.17 | |||||
Price-to-Tangible-Book | 1.17 | |||||
Price-to-Operating-Cash-Flow | 875.14 | |||||
EV-to-EBIT | 10.48 | |||||
EV-to-EBITDA | 7.56 | |||||
EV-to-Revenue | 1.54 | |||||
EV-to-FCF | -27.18 | |||||
Price-to-GF-Value | 0.66 | |||||
Price-to-Graham-Number | 1.77 | |||||
| Price-to-Net-Current-Asset-Value | 2.7 | |||||
Earnings Yield (Greenblatt) % | 9.55 | |||||
FCF Yield % | -3.74 | |||||
Forward Rate of Return (Yacktman) % | 2.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Unichem Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 22,018.5 | ||
| EPS (TTM) (₹) | 35.84 | ||
| Beta | 0.9272 | ||
| 3-Year Sharpe Ratio | -0.03 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 47.53 | ||
| 14-Day RSI | 66.65 | ||
| 14-Day ATR (₹) | 21.946935 | ||
| 20-Day SMA (₹) | 421.04 | ||
| 12-1 Month Momentum % | -40.98 | ||
| 52-Week Range (₹) | 278.2 - 657.95 | ||
| Shares Outstanding (Mil) | 70.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Unichem Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Unichem Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 2.5:1 Stock Split | 2010-10-21 | 219.04 (-3.24%) | ||
| 2:1 Stock Split | 2004-03-16 | 67.92 (-2.27%) | ||
| 2:1 Stock Split | 2000-03-29 | -- |
Show
Entries
Unichem Laboratories Ltd Frequently Asked Questions
What is Unichem Laboratories Ltd(NSE:UNICHEMLAB)'s stock price today?
The current price of NSE:UNICHEMLAB is ₹452.20. The 52 week high of NSE:UNICHEMLAB is ₹657.95 and 52 week low is ₹278.20.
When is next earnings date of Unichem Laboratories Ltd(NSE:UNICHEMLAB)?
The next earnings date of Unichem Laboratories Ltd(NSE:UNICHEMLAB) is .
Does Unichem Laboratories Ltd(NSE:UNICHEMLAB) pay dividends? If so, how much?
Unichem Laboratories Ltd(NSE:UNICHEMLAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Unichem Laboratories Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers